Trials / Available
AvailableNCT06808568
Expanded Access Program (EAP) STIMULAN VG
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Biocomposites Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Individual (single) patient expanded access may be considered.
Detailed description
Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers. Under these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient. Please contact expandedaccess@biocomposites.com for more information.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | STIMULAN VG |
Timeline
- First posted
- 2025-02-05
- Last updated
- 2025-02-05
Source: ClinicalTrials.gov record NCT06808568. Inclusion in this directory is not an endorsement.